Third Wave Licenses Invader, Cleavase to Aclara | GenomeWeb

NEW YORK, Oct. 16 - Aclara will incorporate with its eTag platform Third Wave Technologies' Invader product and Cleavase enzyme for research use and gene-expression assays, the companies said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.